Masimo Debt to Equity Ratio 2010-2025 | MASI
Current and historical debt to equity ratio values for Masimo (MASI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Masimo debt/equity for the three months ending March 31, 2025 was 0.67.
| Masimo Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $1.35B | $0.95B | 1.42 |
| 2024-12-31 | $1.57B | $1.05B | 1.50 |
| 2024-09-30 | $1.63B | $1.46B | 1.11 |
| 2024-06-30 | $1.53B | $1.37B | 1.11 |
| 2024-03-31 | $1.59B | $1.37B | 1.17 |
| 2023-12-31 | $1.68B | $1.37B | 1.23 |
| 2023-09-30 | $1.72B | $1.28B | 1.35 |
| 2023-06-30 | $1.70B | $1.31B | 1.30 |
| 2023-03-31 | $1.79B | $1.33B | 1.34 |
| 2022-12-31 | $1.87B | $1.34B | 1.40 |
| 2022-09-30 | $1.80B | $1.25B | 1.44 |
| 2022-06-30 | $1.76B | $1.20B | 1.46 |
| 2022-03-31 | $0.33B | $1.58B | 0.21 |
| 2021-12-31 | $0.34B | $1.55B | 0.22 |
| 2021-09-30 | $0.30B | $1.47B | 0.20 |
| 2021-06-30 | $0.29B | $1.39B | 0.21 |
| 2021-03-31 | $0.27B | $1.33B | 0.20 |
| 2020-12-31 | $0.31B | $1.41B | 0.22 |
| 2020-09-30 | $0.30B | $1.42B | 0.21 |
| 2020-06-30 | $0.29B | $1.35B | 0.22 |
| 2020-03-31 | $0.22B | $1.25B | 0.18 |
| 2019-12-31 | $0.23B | $1.17B | 0.20 |
| 2019-09-30 | $0.21B | $1.11B | 0.19 |
| 2019-06-30 | $0.19B | $1.04B | 0.18 |
| 2019-03-31 | $0.17B | $1.01B | 0.17 |
| 2018-12-31 | $0.19B | $0.97B | 0.19 |
| 2018-09-30 | $0.18B | $0.91B | 0.20 |
| 2018-06-30 | $0.18B | $0.83B | 0.22 |
| 2018-03-31 | $0.18B | $0.77B | 0.24 |
| 2017-12-31 | $0.18B | $0.72B | 0.25 |
| 2017-09-30 | $0.19B | $0.72B | 0.26 |
| 2017-06-30 | $0.19B | $0.71B | 0.26 |
| 2017-03-31 | $0.24B | $0.63B | 0.38 |
| 2016-12-31 | $0.26B | $0.56B | 0.47 |
| 2016-09-30 | $0.31B | $0.33B | 0.92 |
| 2016-06-30 | $0.31B | $0.30B | 1.04 |
| 2016-03-31 | $0.35B | $0.27B | 1.32 |
| 2015-12-31 | $0.33B | $0.28B | 1.18 |
| 2015-09-30 | $0.31B | $0.27B | 1.15 |
| 2015-06-30 | $0.30B | $0.28B | 1.06 |
| 2015-03-31 | $0.25B | $0.33B | 0.77 |
| 2014-12-31 | $0.26B | $0.31B | 0.84 |
| 2014-09-30 | $0.25B | $0.28B | 0.87 |
| 2014-06-30 | $0.18B | $0.32B | 0.56 |
| 2014-03-31 | $0.11B | $0.35B | 0.30 |
| 2013-12-31 | $0.11B | $0.33B | 0.34 |
| 2013-09-30 | $0.11B | $0.31B | 0.36 |
| 2013-06-30 | $0.10B | $0.29B | 0.35 |
| 2013-03-31 | $0.11B | $0.28B | 0.38 |
| 2012-12-31 | $0.10B | $0.28B | 0.36 |
| 2012-09-30 | $0.10B | $0.31B | 0.30 |
| 2012-06-30 | $0.09B | $0.30B | 0.29 |
| 2012-03-31 | $0.10B | $0.28B | 0.37 |
| 2011-12-31 | $0.09B | $0.28B | 0.31 |
| 2011-09-30 | $0.08B | $0.30B | 0.26 |
| 2011-06-30 | $0.07B | $0.28B | 0.26 |
| 2011-03-31 | $0.07B | $0.26B | 0.29 |
| 2010-12-31 | $0.08B | $0.23B | 0.35 |
| 2010-09-30 | $0.08B | $0.25B | 0.32 |
| 2010-06-30 | $0.07B | $0.23B | 0.33 |
| 2010-03-31 | $0.08B | $0.21B | 0.40 |
| 2009-12-31 | $0.07B | $0.29B | 0.23 |
| 2009-09-30 | $0.07B | $0.27B | 0.24 |
| 2009-06-30 | $0.06B | $0.25B | 0.25 |
| 2009-03-31 | $0.07B | $0.24B | 0.29 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.868B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $201.227B | 88.14 |
| Thermo Fisher Scientific (TMO) | United States | $163.300B | 19.75 |
| Alcon (ALC) | Switzerland | $46.755B | 31.08 |
| Edwards Lifesciences (EW) | United States | $43.878B | 28.77 |
| IDEXX Laboratories (IDXX) | United States | $40.977B | 47.09 |
| DexCom (DXCM) | United States | $33.349B | 51.54 |
| IQVIA Holdings (IQV) | United States | $27.010B | 15.13 |
| Mettler-Toledo (MTD) | United States | $24.411B | 29.03 |
| STERIS (STE) | Ireland | $22.902B | 26.19 |
| Waters (WAT) | United States | $21.820B | 30.79 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.782B | 0.00 |
| Hologic (HOLX) | United States | $13.106B | 14.24 |
| Penumbra (PEN) | United States | $11.523B | 90.44 |
| Sysmex ADR (SSMXY) | Japan | $11.349B | 0.00 |
| Globus Medical (GMED) | United States | $8.116B | 19.03 |
| Teleflex (TFX) | United States | $5.711B | 9.43 |
| Glaukos (GKOS) | United States | $5.408B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.211B | 22.07 |
| TransMedics (TMDX) | United States | $4.016B | 87.30 |
| PROCEPT BioRobotics (PRCT) | United States | $3.012B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.466B | 14.69 |
| Veracyte (VCYT) | United States | $2.409B | 33.80 |
| Nihon Kohden (NHNKY) | Japan | $2.072B | 11.33 |
| Elekta AB (EKTAY) | Sweden | $1.983B | 17.83 |
| Alphatec Holdings (ATEC) | United States | $1.852B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.562B | 0.00 |
| Artivion (AORT) | United States | $1.229B | 115.08 |
| Pulse Biosciences (PLSE) | United States | $1.130B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.062B | 5.65 |
| OPKO Health (OPK) | United States | $0.999B | 0.00 |
| SiBone (SIBN) | United States | $0.800B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.696B | 15.20 |
| IRadimed (IRMD) | United States | $0.668B | 33.92 |
| Beta Bionics (BBNX) | United States | $0.615B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.606B | 9.42 |
| OrthoPediatrics (KIDS) | United States | $0.565B | 0.00 |
| RxSight (RXST) | United States | $0.559B | 0.00 |
| AxoGen (AXGN) | United States | $0.519B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.503B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.485B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.452B | 0.00 |
| NeuroPace (NPCE) | United States | $0.438B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.382B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.334B | 7.10 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Neuronetics (STIM) | United States | $0.273B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.226B | 13.69 |
| 908 Devices (MASS) | United States | $0.205B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.197B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.166B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.163B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.126B | 0.00 |
| CVRx (CVRX) | United States | $0.124B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.116B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.108B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.093B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.075B | 11.38 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.053B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 15.25 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.06 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |